Revision of the EU rules on genetically modified micro‑organisms and the processing of organs
Summary
During its November II plenary session, the European Parliament is due to vote on its position on a proposal for a directive amending two directives as regards the placing on the market of genetically modified micro‑organisms and the processing of organs, accompanying the proposed European biotech act.
Translations are available for this publication.
Statement of purpose
First‑reading report: 2025/0405(COD); Committees responsible: ENVI and SANT; Rapporteurs: Marta Temido (S&D, Portugal) and Adam Jarubas (EPP, Poland). For further information see the Legislative Train Schedule.
Background
Genetically modified micro‑organisms (GMMs) are micro‑organisms whose genetic material has been altered in a way that does not occur naturally through mating and/or natural recombination. They include bacteria, archaea, fungi, protozoa, chromista (algae) and certain viruses. Genetic modification can give these micro‑organisms new or enhanced characteristics, enabling applications across a wide range of sectors. However, the use of GMMs may also entail risks for human and environmental health.
European Commission proposal
On 16 December 2025, the European Commission put forward a proposal for a directive amending Directives 2001/18/EC on the deliberate release into the environment of genetically modified organisms and 2010/53/EU on standards of quality and safety of human organs intended for transplantation. The aim was to update and clarify EU rules on the placing on the market of GMMs and on the processing of human organs intended for transplantation. According to the Commission, the proposed amendments on GMMs would introduce a more tailored, efficient and streamlined regulatory framework, facilitating their development, production and marketing in the EU, while maintaining high standards for the protection of human health and the environment. Key amendments concern risk assessment requirements adapted to GMMs' specific characteristics, the validity of the consent granted for placing GMMs on the market, the methods for detecting them in products placed on the market, and the reduction of administrative burden. The proposal also introduces the concept of 'low‑risk' GMMs, based on scientific criteria, and provides for a streamlined authorisation procedure for eligible low‑risk GMMs. Regarding organs, to reflect advances in medical science and changes in transplantation practices, the Commission proposes extending the scope of Directive 2010/53/EU to cover organ processing alongside organ donation. Organ processing would encompass operations performed on organs prior to transplantation, including their handling and preservation, and the application of chemotherapy and surgery to maintain or improve organ function. The proposal to amend the two directives complements the proposed regulation for a European biotech act.
European Parliament position
On 2 September 2026, the Committees on the Environment, Climate and Food Safety (ENVI) and on Public Health (SANT) considered a joint draft report on the proposal. The final report was adopted on 10 November 2026 with 54 votes in favour, 18 votes against, and 16 abstentions. For GMMs, open‑ended authorisation would be granted only at the first renewal, after an initial 10‑year period. On organ donation, cross‑border EU cooperation would be improved. Once voted in plenary, the report will set Parliament's position for negotiations with the Council. The Council adopted its position on 16 June 2026.
Classification
Policy areas: Environment | Public Health
Regions: European Union
Committees: Environment, Climate and Food Safety (ENVI), Public Health (SANT)
Statement on the use of AI
Any AI‑generated content in this text has been reviewed by the author(s).
Disclaimer
This document is prepared for, and addressed to, the Members and staff of the European Parliament as background material to assist them in their parliamentary work. The content of the document is the sole responsibility of its author(s) and any opinions expressed herein should not be taken to represent an official position of the Parliament.
